Probabilistic sensitivity analysis for NICE technology assessment: not an optional extra
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Cost-Effectiveness in Health and Medicine
1996 • 6,853 citations
Representing uncertainty: the role of cost‐effectiveness acceptability curves
2001 • 1,022 citations
Costs, effects and C/E‐ratios alongside a clinical trial
1994 • 947 citations
The irrelevance of inference: a decision-making approach to the stochastic evaluation of health care technologies
1999 • 886 citations
Probabilistic Sensitivity Analysis Using Monte Carlo Simulation
1985 • 820 citations
The CE Plane
1990 • 523 citations
A rational framework for decision making by the National Institute For Clinical Excellence (NICE)
2002 • 459 citations
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE (NICE)
2002 • 418 citations
In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care
1994 • 415 citations
An economic approach to clinical trial design and research priority-setting
1996 • 396 citations
Thinking Outside the Box: Recent Advances in the Analysis and Presentation of Uncertainty in Cost-Effectiveness Studies
2002 • 392 citations
Expected Value of Sample Information Calculations in Medical Decision Modeling
2004 • 371 citations
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease
2002 • 355 citations
Health Economic Guidelines—Similarities, Differences and Some Implications
2001 • 330 citations
Probabilistic Analysis of Cost-Effectiveness Models: Choosing between Treatment Strategies for Gastroesophageal Reflux Disease
2002 • 296 citations
A Bayesian approach to stochastic cost-effectiveness analysis
1999 • 246 citations
Probabilistic Analysis of Decision Trees Using Monte Carlo Simulation
1986 • 196 citations
BAYESIAN VALUE-OF-INFORMATION ANALYSIS
2001 • 182 citations
Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation
2002 • 155 citations
Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis * Commentary: Evaluating disease modifying treatments in multiple sclerosis
2003 • 137 citations
Incorporating option values into the economic evaluation of health care technologies
2000 • 119 citations
Addressing uncertainty in medical cost–effectiveness analysis
2001 • 93 citations
Gaussian Process Modeling in Conjunction with Individual Patient Simulation Modeling: A Case Study Describing the Calculation of Cost-Effectiveness Ratios for the Treatment of Established Osteoporosis
2004 • 83 citations
Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty
2002 • 83 citations
Markov Chain Monte Carlo Estimation of a Multiparameter Decision Model: Consistency of Evidence and the Accurate Assessment of Uncertainty
2002 • 77 citations
Cited By (0)
No citing papers found in database